Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Short-term Investments: 2015-2017

Historic Short-term Investments for Tvardi Therapeutics (TVRD) over the last 2 years, with Sep 2017 value amounting to $91.2 million.

  • Tvardi Therapeutics' Short-term Investments rose 38.18% to $91.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $91.2 million, marking a year-over-year increase of 38.18%. This contributed to the annual value of $46.2 million for FY2016, which is 49.60% down from last year.
  • Tvardi Therapeutics' Short-term Investments amounted to $91.2 million in Q3 2017, which was down 11.48% from $103.0 million recorded in Q2 2017.
  • In the past 5 years, Tvardi Therapeutics' Short-term Investments registered a high of $103.0 million during Q2 2017, and its lowest value of $31.5 million during Q1 2017.
  • Over the past 3 years, Tvardi Therapeutics' median Short-term Investments value was $84.8 million (recorded in 2016), while the average stood at $74.9 million.
  • Data for Tvardi Therapeutics' Short-term Investments shows a peak YoY increase of 38.18% (in 2017) and a maximum YoY decrease of 64.33% (in 2017) over the last 5 years.
  • Tvardi Therapeutics' Short-term Investments (Quarterly) stood at $91.6 million in 2015, then crashed by 49.60% to $46.2 million in 2016, then soared by 38.18% to $91.2 million in 2017.
  • Its Short-term Investments stands at $91.2 million for Q3 2017, versus $103.0 million for Q2 2017 and $31.5 million for Q1 2017.